Literature DB >> 15571963

Sheep and goats: separating cervix and corpus uteri from imprecisely coded uterine cancer deaths, for studies of geographical and temporal variations in mortality.

A H Loos1, F Bray, P McCarron, E Weiderpass, M Hakama, D M Parkin.   

Abstract

Analysing time trends in mortality from cancers of the cervix and corpus uteri using routine data sources (such as the World Health Organisation mortality database) involves two major problems: deaths certified as "uterus, unspecified site", and the presence of a combined category comprising unspecified and corpus uteri cancer deaths. To avoid misleading interpretations, the unspecified and the misclassified data must be incorporated into the analysis to produce rates that allow meaningful comparisons between populations and over time. Reallocation methods based on age- and time-specific distributions of cervix and corpus uteri cancer are applied to the unspecified deaths, while for those in the combined category, the age- and time-specific distributions of unspecified and corpus uteri cancer are considered. Adjustments of the general strategies for reallocation were developed to take into account the different quality of the data. Results from eight European countries with different degrees of coding precision are presented. The reallocation methods bring the cervix and corpus uteri mortality trends more in line with the trends for countries with more precise data while keeping the country-specific characteristics. In addition, the methods ensured the availability of time trends for corpus uteri cancer in women age 50 years and older, which were completely missing without reallocation. We propose generally applicable reallocation methods that allow valid time trend analysis of cervix and corpus uteri cancer mortality using datasets of varying precision. Our results show that any sensible analysis of time trends must involve procedures for correcting for unspecified and misclassified uterine cancer deaths. The modified data are available at .

Entities:  

Mesh:

Year:  2004        PMID: 15571963     DOI: 10.1016/j.ejca.2004.09.007

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  14 in total

Review 1.  Economic evaluation of human papilloma virus vaccination in the European Union: a critical review.

Authors:  Daniela Koleva; Paola De Compadri; Anna Padula; Livio Garattini
Journal:  Intern Emerg Med       Date:  2011-02-11       Impact factor: 3.397

2.  Trends in inequalities in premature cancer mortality by educational level in Colombia, 1998-2007.

Authors:  Esther de Vries; Ivan Arroyave; Constanza Pardo; Carolina Wiesner; Raul Murillo; David Forman; Alex Burdorf; Mauricio Avendaño
Journal:  J Epidemiol Community Health       Date:  2014-12-09       Impact factor: 3.710

3.  How protective is cervical cancer screening against cervical cancer mortality in developing countries? The Colombian case.

Authors:  Luz Angela Chocontá-Piraquive; Nelson Alvis-Guzman; Fernando De la Hoz-Restrepo
Journal:  BMC Health Serv Res       Date:  2010-09-16       Impact factor: 2.655

4.  Cervical and female breast cancers in the Americas: current situation and opportunities for action.

Authors:  Silvana Luciani; Anna Cabanes; Elisa Prieto-Lara; Vilma Gawryszewski
Journal:  Bull World Health Organ       Date:  2013-09-01       Impact factor: 9.408

5.  The end of the decline in cervical cancer mortality in Spain: trends across the period 1981-2012.

Authors:  Marta Cervantes-Amat; Gonzalo López-Abente; Nuria Aragonés; Marina Pollán; Roberto Pastor-Barriuso; Beatriz Pérez-Gómez
Journal:  BMC Cancer       Date:  2015-04-15       Impact factor: 4.430

6.  Trends in gynecologic cancer mortality in East Asian regions.

Authors:  Jung-Yun Lee; Eun-Yang Kim; Kyu-Won Jung; Aesun Shin; Karen K L Chan; Daisuke Aoki; Jae-Weon Kim; Jeffrey J H Low; Young-Joo Won
Journal:  J Gynecol Oncol       Date:  2014-07-03       Impact factor: 4.401

7.  An assessment of GLOBOCAN methods for deriving national estimates of cancer incidence.

Authors:  Sebastien Antoni; Isabelle Soerjomataram; Bjørn Møller; Freddie Bray; Jacques Ferlay
Journal:  Bull World Health Organ       Date:  2016-01-28       Impact factor: 9.408

8.  Cancer incidence estimates and mortality for the top five cancer in Colombia, 2007-2011.

Authors:  Constanza Pardo; Ricardo Cendales
Journal:  Colomb Med (Cali)       Date:  2018-03-30

Review 9.  Maps and atlases of cancer mortality: a review of a useful tool to trigger new questions.

Authors:  Alberto d'Onofrio; Chiara Mazzetta; Chris Robertson; Michel Smans; Peter Boyle; Mathieu Boniol
Journal:  Ecancermedicalscience       Date:  2016-09-01

10.  The role of socio-demographic factors in premature cervical cancer mortality in Colombia.

Authors:  Silvia Bermedo-Carrasco; Cheryl L Waldner
Journal:  BMC Public Health       Date:  2016-09-15       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.